Education
About Us
Working with TipRanks
Follow Us
Regencell Bioscience Holdings Ltd. (RGC)
:RGC
RGC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.03 - $32.44
Previous CloseN/A
Volume4.26K
Average Volume (3M)26.18K
Market Cap
$59.86M
Enterprise ValueN/A
Total Cash (Recent Filing)$386.98K
Total Debt (Recent Filing)$3.07M
Price to Earnings (P/E)―
Beta-2.42
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.33
Shares Outstanding13,012,866
10 Day Avg. Volume16,057
30 Day Avg. Volume26,184
Standard Deviation0.57
R-Squared0.00258
Alpha0.06
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Regencell Bioscience News
PremiumCompany Announcements
Regencell Bioscience Extends Lock-Up Period for Stock Options
---
Ownership Overview
―
Insiders
0.05%
Mutual Funds
― Other Institutional Investors
99.95% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
RGC FAQ
What was Regencell Bioscience Holdings Ltd.’s price range in the past 12 months?
Regencell Bioscience Holdings Ltd. lowest stock price was $3.03 and its highest was $32.44 in the past 12 months.
What is Regencell Bioscience Holdings Ltd.’s market cap?
Regencell Bioscience Holdings Ltd.’s market cap is $59.86M.
When is Regencell Bioscience Holdings Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Regencell Bioscience Holdings Ltd.’s earnings last quarter?
Currently, no data Available
Is Regencell Bioscience Holdings Ltd. overvalued?
According to Wall Street analysts Regencell Bioscience Holdings Ltd.’s price is currently Overvalued.
Does Regencell Bioscience Holdings Ltd. pay dividends?
Regencell Bioscience Holdings Ltd. does not currently pay dividends.
What is Regencell Bioscience Holdings Ltd.’s EPS estimate?
Regencell Bioscience Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Regencell Bioscience Holdings Ltd. have?
Regencell Bioscience Holdings Ltd. has 13,012,866 shares outstanding.
What happened to Regencell Bioscience Holdings Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Regencell Bioscience Holdings Ltd.?
Currently, no hedge funds are holding shares in RGC
---
Regencell Bioscience Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-34.84%
12-Months-Change
Fundamentals
Return on Equity
-42.49%
Trailing 12-Months
Asset Growth
-33.15%
Trailing 12-Months
Company Description
Regencell Bioscience Holdings Ltd.
Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.
---
Technical Analysis
---